Overall | Group_A | Group_B | P value | |
---|---|---|---|---|
Cases | 234 | 112 | 122 | |
Age [mean (SD)] | 66.92 (7.80) | 67.07 (8.75) | 66.79 (6.85) | 0.781 |
TPSA [mean (SD)] | 13.90 (6.43) | 14.22 (6.24) | 13.60 (6.62) | 0.465 |
Biopsy Gleason scores (%) | 0.597 | |||
3 + 3 | 69 (29.5) | 29 (25.9) | 40 (32.8) | |
3 + 4 | 49 (20.9) | 28 (25.0) | 21 (17.2) | |
3 + 5 | 14 (6.0) | 5 (4.5) | 9 (7.4) | |
4 + 3 | 85 (36.3) | 41 (36.6) | 44 (36.1) | |
4 + 4 | 6 (2.6) | 3 (2.7) | 3 (2.5) | |
4 + 5 | 11 (4.7) | 6 (5.4) | 5 (4.1) | |
cT stage (%) | 0.638 | |||
cT2a | 11 (4.7) | 4 (3.6) | 7 (5.7) | |
cT2b | 32 (13.7) | 14 (12.5) | 18 (14.8) | |
cT2c | 160 (68.4) | 81 (72.3) | 79 (64.8) | |
cT3a | 28 (12.0) | 11 (9.8) | 17 (13.9) | |
cT3b | 3 (1.3) | 2 (1.8) | 1 (0.8) |